• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶因子与心绞痛患者心肌梗死或猝死风险。欧洲冠心病预防试验(ECAT)研究组。欧洲血栓形成与残疾联合行动组织。

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.

作者信息

Juhan-Vague I, Pyke S D, Alessi M C, Jespersen J, Haverkate F, Thompson S G

机构信息

Hematology Laboratory, CHU Timone, Marseille, France.

出版信息

Circulation. 1996 Nov 1;94(9):2057-63. doi: 10.1161/01.cir.94.9.2057.

DOI:10.1161/01.cir.94.9.2057
PMID:8901651
Abstract

BACKGROUND

Disturbances of the fibrinolytic system that lead to decreased removal of fibrin deposits may be important risk factors for coronary thrombosis. There is as yet no consensus on the prognostic value of fibrinolytic parameters, which may be attributed in part to the choice of confounding variables controlled for.

METHODS AND RESULTS

The ECAT study is a prospective multicenter study of 3043 patients with angina pectoris followed for 2 years. Baseline measurements included 10 fibrinolytic variables. The results were analyzed in relation to the subsequent incidence of myocardial infarction or sudden coronary death. They are presented before and after adjustment for clusters of confounding variables that are markers of different mechanisms: insulin resistance (body mass index, triglyceride, and HDL cholesterol), inflammation (fibrinogen and C-reactive protein), and endothelial cell damage (von Willebrand factor). An increased incidence of events was associated with higher baseline concentrations of tissue plasminogen activator (TPA) antigen (P = .0002), plasminogen activator inhibitor-1 (PAI-1) activity (P = .02), and PAI-1 antigen (P = .001). The associations of PAI-1 activity and PAI-1 antigen with risk of events disappeared after adjustment for parameters reflecting insulin resistance but were not affected by other adjustments. TPA antigen was affected to a similar extent by adjustment for parameters reflecting insulin resistance. Inflammation, or endothelial cell damage, but the risk association disappeared only after combined adjustments.

CONCLUSIONS

The prognostic role of PAI-1 in predicting coronary events is related principally to insulin resistance, whereas that of TPA antigen could be explained only by its relationship with different mechanisms, including insulin resistance, inflammation and endothelial cell damage.

摘要

背景

纤溶系统紊乱导致纤维蛋白沉积清除减少,可能是冠状动脉血栓形成的重要危险因素。关于纤溶参数的预后价值尚无共识,这可能部分归因于所控制的混杂变量的选择。

方法与结果

ECAT研究是一项对3043例心绞痛患者进行为期2年随访的前瞻性多中心研究。基线测量包括10个纤溶变量。分析结果与随后心肌梗死或心源性猝死发生率的关系。在对作为不同机制标志物的混杂变量簇进行调整前后呈现结果:胰岛素抵抗(体重指数、甘油三酯和高密度脂蛋白胆固醇)、炎症(纤维蛋白原和C反应蛋白)和内皮细胞损伤(血管性血友病因子)。事件发生率增加与组织纤溶酶原激活物(TPA)抗原基线浓度较高(P = 0.0002)、纤溶酶原激活物抑制剂-1(PAI-1)活性(P = 0.02)和PAI-1抗原(P = 0.001)相关。在对反映胰岛素抵抗的参数进行调整后,PAI-1活性和PAI-1抗原与事件风险的关联消失,但不受其他调整的影响。TPA抗原在对反映胰岛素抵抗、炎症或内皮细胞损伤的参数进行调整时受到类似程度的影响,但仅在联合调整后风险关联才消失。

结论

PAI-1在预测冠状动脉事件中的预后作用主要与胰岛素抵抗有关,而TPA抗原的预后作用只能通过其与包括胰岛素抵抗、炎症和内皮细胞损伤在内的不同机制的关系来解释。

相似文献

1
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.纤溶因子与心绞痛患者心肌梗死或猝死风险。欧洲冠心病预防试验(ECAT)研究组。欧洲血栓形成与残疾联合行动组织。
Circulation. 1996 Nov 1;94(9):2057-63. doi: 10.1161/01.cir.94.9.2057.
2
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.止血因素与心绞痛患者心肌梗死或猝死风险。欧洲血栓形成与残疾协同行动心绞痛研究组
N Engl J Med. 1995 Mar 9;332(10):635-41. doi: 10.1056/NEJM199503093321003.
3
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.止血系统与胰岛素抵抗综合征的关系。对1500例心绞痛患者的研究。欧洲冠心病心绞痛研究组
Arterioscler Thromb. 1993 Dec;13(12):1865-73. doi: 10.1161/01.atv.13.12.1865.
4
Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.在斯德哥尔摩心脏流行病学项目(SHEEP)研究中,血浆组织型纤溶酶原激活剂/纤溶酶原激活剂抑制剂-1复合物水平和血管性血友病因子是复发性心肌梗死的重要风险标志物。
Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):2019-23. doi: 10.1161/01.atv.20.8.2019.
5
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.在一项心肌梗死前瞻性研究(PRIME研究,即心肌梗死前瞻性流行病学研究)的10500名男性参与者中,纤维蛋白原、凝血因子VII和纤溶酶原激活物抑制剂-1与基线检查结果的相关性。
Thromb Haemost. 1998 Nov;80(5):749-56.
6
Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.维拉帕米或美托洛尔治疗稳定型心绞痛患者的纤溶变量与心血管预后。斯德哥尔摩心绞痛预后研究结果。
Circulation. 1997 May 20;95(10):2380-6. doi: 10.1161/01.cir.95.10.2380.
7
High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.血浆中纤溶酶原激活物抑制剂和组织纤溶酶原激活物水平升高在男性和女性首次急性心肌梗死之前出现:纤溶系统作为独立主要危险因素的证据。
Circulation. 1998 Nov 24;98(21):2241-7. doi: 10.1161/01.cir.98.21.2241.
8
Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.既往有心肌梗死病史的中年女性在急性体育锻炼后纤溶反应保留且无凝血激活。
Thromb Res. 2002 Mar 15;105(6):481-6. doi: 10.1016/s0049-3848(02)00063-4.
9
Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.循环炎症和止血生物标志物与老年男性心肌梗死和冠状动脉死亡风险相关,但与心绞痛无关。
J Thromb Haemost. 2009 Oct;7(10):1605-11. doi: 10.1111/j.1538-7836.2009.03574.x. Epub 2009 Aug 11.
10
Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.杂合子家族性高胆固醇血症心肌梗死年轻幸存者的纤溶参数与胰岛素抵抗
Wien Klin Wochenschr. 2001 Feb 15;113(3-4):113-8.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
Plasminogen Activation Inhibitor-1 Promotes Resilience to Acute Oxidative Stress in Cerebral Arteries from Females.纤溶酶原激活物抑制剂-1促进雌性脑动脉对急性氧化应激的耐受性。
Pharmaceuticals (Basel). 2024 Sep 14;17(9):1210. doi: 10.3390/ph17091210.
3
Metabolic landscape in venous thrombosis: insights into molecular biology and therapeutic implications.
静脉血栓形成中的代谢景观:分子生物学的见解和治疗意义。
Ann Med. 2024 Dec;56(1):2401112. doi: 10.1080/07853890.2024.2401112. Epub 2024 Sep 19.
4
Identification of genomic loci regulating platelet plasminogen activator inhibitor-1 in mice.鉴定调控小鼠血小板纤溶酶原激活物抑制剂-1的基因组位点。
J Thromb Haemost. 2023 Oct;21(10):2917-2928. doi: 10.1016/j.jtha.2023.06.018. Epub 2023 Jun 25.
5
Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction.心肌梗死患者全血在高剪切力下内源性纤维蛋白溶解的决定因素
JACC Basic Transl Sci. 2022 Aug 24;7(11):1069-1082. doi: 10.1016/j.jacbts.2022.05.007. eCollection 2022 Nov.
6
Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study.患有射血分数保留型心力衰竭(HFpEF)的患者中的血管性血友病因子(vWF):一项回顾性观察性研究。
Medicine (Baltimore). 2022 Aug 5;101(31):e29854. doi: 10.1097/MD.0000000000029854.
7
Acute Myocardial Infarction in a 9-Year-Old Boy Due to Multisystem Inflammatory Syndrome.一名9岁男孩因多系统炎症综合征引发急性心肌梗死。
Anatol J Cardiol. 2022 Jul;26(7):580-583. doi: 10.5152/AnatolJCardiol.2022.1491.
8
PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?PAI-1:阻塞性睡眠呼吸暂停中血管功能障碍的主要参与者?
Int J Mol Sci. 2022 May 15;23(10):5516. doi: 10.3390/ijms23105516.
9
Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction.糖尿病和冠心病患者的微粒体血管生成含量可预测内皮功能障碍网络。
Cardiovasc Diabetol. 2022 Feb 2;21(1):17. doi: 10.1186/s12933-022-01449-0.
10
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease.一种在多种蛋白酶抑制物中起作用的丝氨酸蛋白酶抑制剂:纤溶酶原激活物抑制剂-1在血栓炎症和心血管疾病中的核心作用
Front Cardiovasc Med. 2021 Apr 16;8:653655. doi: 10.3389/fcvm.2021.653655. eCollection 2021.